Recent Advances in Using Marine Microorganisms for New Bioactive Natural Products

Kehan Milton^*
*Correspondence: Kehan Milton, University of Illinois Chicago, Chicago, USA, Email:

Received: 02-Jan-2025, Manuscript No. Ijdrt-25-163394; Editor assigned: 04-Jan-2025, Pre QC No. P-163394; Reviewed: 17-Jan-2025, QC No. Q-163394; Revised: 23-Jan-2025, Manuscript No. R-163394; Published: 31-Jan-2025, DOI: 10.37421/2277-1506.2025.14.487

Introduction

Marine microorganisms have emerged as an invaluable source of bioactive natural products with significant potential for pharmaceutical, agricultural, and industrial applications. Over the past decade, advancements in biotechnology, genomics, and analytical chemistry have facilitated the discovery and exploitation of these microorganisms, leading to the identification of novel compounds with diverse biological activities. The unique environmental conditions of marine ecosystems, including high pressure, extreme temperatures, and limited nutrients, have driven the evolution of microbial species capable of producing structurally diverse secondary metabolites with potent bioactivity. Advancements in metagenomics and genome mining have played a pivotal role in uncovering the vast biosynthetic potential of marine microorganisms. Many marine-derived bioactive compounds remain undiscovered due to the limitations of traditional culture-based methods. The application of high-throughput sequencing and bioinformatics tools has enabled researchers to access and analyze microbial genomes, revealing cryptic biosynthetic gene clusters responsible for the production of novel natural products. By leveraging synthetic biology approaches, scientists have been able to activate and optimize these biosynthetic pathways, leading to the enhanced production of bioactive compounds.

Description

Marine-derived natural products have demonstrated a wide range of pharmacological activities, including antimicrobial, anticancer, antiviral, and anti-inflammatory properties. The urgent need for new antibiotics to combat multidrug-resistant pathogens has driven interest in marine microorganisms as a source of novel antimicrobial agents. Several marine-derived compounds have exhibited potent antibacterial and antifungal activity, with some advancing to preclinical and clinical development. Produced by the marine, has shown promise as a proteasome inhibitor for the treatment of multiple myeloma. Beyond antimicrobial applications, marine microorganisms have yielded promising anticancer agents. Compounds such are derived from a marine bacterium associated with the tunicate have been approved for cancer therapy due to their ability to interfere with DNA repair mechanisms. Other marine-derived cytotoxic compounds have exhibited selective activity against cancer cells while minimizing toxicity to normal cells, highlighting their potential as lead candidates for anticancer drug development [1-3].

The antiviral properties of marine-derived natural products have also garnered significant attention, particularly in the search for new treatments against emerging viral infections. Several marine microbial metabolites have demonstrated inhibitory effects against viruses such as influenza, HIV, and coronaviruses. The structural complexity and unique mechanisms of action of these compounds provide a foundation for the development of novel antiviral therapies, addressing the limitations of existing antiviral drugs and the challenge of viral resistance. In addition to their pharmaceutical potential, bioactive compounds from marine microorganisms have been explored for applications in agriculture and biotechnology. Natural products with insecticidal, antifungal, and plant growth-promoting properties offer eco-friendly alternatives to synthetic agrochemicals. Marine-derived enzymes and biosurfactants have found applications in industrial processes, including bioremediation, food preservation, and cosmetic formulations. The stability and efficacy of these bioactive compounds under extreme environmental conditions make them particularly attractive for commercial applications [4,5].

Conclusion

Despite the remarkable progress in the discovery of marine natural products, challenges remain in translating these compounds into commercially viable products. Issues such as low yields, complex structural modifications, and sustainable supply chains need to be addressed to facilitate large-scale production. Advances in fermentation technology, metabolic engineering, and synthetic biology are being applied to enhance the yield and scalability of marine-derived compounds. Additionally, the development of innovative bioprocessing techniques, including heterologous expression systems and co-culture strategies, has improved the feasibility of harnessing marine microbial metabolites. The exploration of marine microorganisms as sources of bioactive natural products continues to expand, driven by interdisciplinary collaborations and technological innovations. Future research will focus on unlocking the full biosynthetic potential of marine microbes, optimizing the production of valuable compounds, and integrating marine biotechnology into drug discovery pipelines. As the demand for novel bioactive molecules grows, the marine environment remains a promising and largely untapped reservoir of chemical diversity, offering solutions to pressing challenges in medicine, agriculture, and industry.

Acknowledgement

None.

Conflict of Interest

None.

References

1. Smanski, Michael J., Hui Zhou, Jan Claesen and Ben Shen, et al. "Synthetic biology to access and expand nature's chemical diversity." Nat Rev Microbiol 14 (2016): 135-149.

Google Scholar Cross Ref Indexed at

2. Goering, Anthony W., Ryan A. McClure, James R. Doroghazi and Jessica C. Albright, et al. "Metabologenomics: Correlation of microbial gene clusters with metabolites drives discovery of a nonribosomal peptide with an unusual amino acid monomer." ACS Cent Sci 2 (2016): 99-108.

Google Scholar Cross Ref Indexed at

3. Menna, Marialuisa, Concetta Imperatore, Alfonso Mangoni and Gerardo Della Sala, et al. "Challenges in the configuration assignment of natural products. A case-selective perspective." Nat Prod Rep 36 (2019): 476-489.

Google Scholar Cross Ref Indexed at

4. Fuhrman, Jed A., Jacob A. Cram and David M. Needham. "Marine microbial community dynamics and their ecological interpretation." Nat Rev Microbiol 13 (2015): 133-146.

Google Scholar Cross Ref Indexed at

5. Rodrigues, Carlos JC and Carla CCR de Carvalho. "Cultivating marine bacteria under laboratory conditions: Overcoming the “unculturable” dogma." Front Bioeng Biotechnol 10 (2022): 964589

Google Scholar Cross Ref Indexed at